Medical Management for Fracture Prevention in Children with Osteogenesis Imperfecta
- PMID: 38553634
- PMCID: PMC11606989
- DOI: 10.1007/s00223-024-01202-7
Medical Management for Fracture Prevention in Children with Osteogenesis Imperfecta
Abstract
There are no licensed treatments for children with osteogenesis imperfecta. Children currently receive off-label treatment with bisphosphonates, without any consistent approach to dose, drug or route of administration. Meta-analyses suggest that anti-fracture efficacy of such interventions is equivocal. New therapies are undergoing clinical trials, and it is likely that one or more will receive marketing authorisation within the next three to five years. The long-term outcome from such interventions will need to be studied carefully well beyond the period over which the clinical trials are conducted, and a consistent approach to the collection of data in this regard will be needed as a major collaborative effort.
Keywords: Anti-TGFb antibody; Anti-sclerostin antibody; Bisphosphonate; Denosumab; Mesenchymal stem cell therapy.
© 2024. The Author(s).
Similar articles
-
Interventions for Improving Bone Mineral Density and Reducing Fracture Risk in Osteogenesis Imperfecta: A Mixed Treatment Comparison Network Meta-analysis of Randomized Controlled Clinical Trials.Curr Clin Pharmacol. 2018;13(3):190-198. doi: 10.2174/1574884713666180829143927. Curr Clin Pharmacol. 2018. PMID: 30160216 Review.
-
Bisphosphonates for the prevention of fractures in osteogenesis imperfecta: meta-analysis of placebo-controlled trials.J Bone Miner Res. 2015 May;30(5):929-33. doi: 10.1002/jbmr.2410. J Bone Miner Res. 2015. PMID: 25407702
-
Approach to the Patient: Pharmacological Therapies for Fracture Risk Reduction in Adults With Osteogenesis Imperfecta.J Clin Endocrinol Metab. 2023 Jun 16;108(7):1787-1796. doi: 10.1210/clinem/dgad035. J Clin Endocrinol Metab. 2023. PMID: 36658750 Free PMC article. Review.
-
Osteogenesis imperfecta: from diagnosis and multidisciplinary treatment to future perspectives.Swiss Med Wkly. 2016 Jun 20;146:w14322. doi: 10.4414/smw.2016.14322. eCollection 2016. Swiss Med Wkly. 2016. PMID: 27346233
-
Oral Bisphosphonate Therapy for Osteogenesis Imperfecta: A Systematic Review and Meta-Analysis of Six Randomized Placebo-Controlled Trials.Orthop Surg. 2020 Aug;12(4):1293-1303. doi: 10.1111/os.12611. Epub 2020 Jun 26. Orthop Surg. 2020. PMID: 32589343 Free PMC article.
Cited by
-
A Dyadic Nosology for Osteogenesis Imperfecta and Bone Fragility Syndromes 2024.Calcif Tissue Int. 2024 Dec;115(6):873-890. doi: 10.1007/s00223-024-01248-7. Epub 2024 Jun 28. Calcif Tissue Int. 2024. PMID: 38942908 Free PMC article. Review.
-
Comprehensive Review of Osteogenesis Imperfecta: Current Treatments and Future Innovations.Hum Gene Ther. 2025 Mar;36(5-6):597-617. doi: 10.1089/hum.2024.191. Epub 2025 Feb 11. Hum Gene Ther. 2025. PMID: 39932815 Review.
-
Osteogenesis Imperfecta from Bench to Bedside and from Cradle to Grave.Calcif Tissue Int. 2024 Dec;115(6):775-776. doi: 10.1007/s00223-024-01304-2. Epub 2024 Nov 20. Calcif Tissue Int. 2024. PMID: 39565402 No abstract available.
-
Mesenchymal stem cells in treating human diseases: molecular mechanisms and clinical studies.Signal Transduct Target Ther. 2025 Aug 22;10(1):262. doi: 10.1038/s41392-025-02313-9. Signal Transduct Target Ther. 2025. PMID: 40841367 Free PMC article. Review.
-
Six at Sixty. Commentary on osteogenesis imperfecta 1975-2025.J Med Genet. 2025 May 27;62(6):422-426. doi: 10.1136/jmg-2025-110807. J Med Genet. 2025. PMID: 40425277 Free PMC article.
References
-
- Cooper C, Dennison EM, Leufkens HG, Bishop N, van Staa TP (2004) Epidemiology of childhood fractures in Britain: a study using the general practice research database. J Bone Miner Res 19(12):1976–1981 - PubMed
-
- Goulding A, Jones IE, Williams SM, Grant AM, Taylor RW, Manning PJ, Langley J (2005) First fracture is associated with increased risk of new fractures during growth. J Pediatr 146(2):286–288 - PubMed
-
- Bishop N (2016) Bone material properties in osteogenesis imperfecta. J Bone Miner Res 31(4):699–708 - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical